HemaCell Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B1

  • Latest Deal Amount
  • $14.2M

  • Investors
  • 25

HemaCell General Information

Description

Developer of platelets produced in vitro and related drugs based in Suzhou, Jiangsu. The company focuses on solving the urgent need for platelets in diseases such as cancer, liver disease, critical illness, and hematological diseases, thereby developing innovative drugs for various diseases related to platelet abnormalities, and providing clients with effective treatment plans.

Contact Information

Website
www.xuejibio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5th Floor, Building 5, Block B, Phase V of the Biomedical Industrial Park
  • Number 21 Dongyanli Road, Suzhou Industrial Park
  • Suzhou, Jiangsu 215000
  • China
+86 0512
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 5th Floor, Building 5, Block B, Phase V of the Biomedical Industrial Park
  • Number 21 Dongyanli Road, Suzhou Industrial Park
  • Suzhou, Jiangsu 215000
  • China
+86 0512

HemaCell Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HemaCell Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Early Stage VC (Series B1) 26-Dec-2025 $14.2M Completed Generating Revenue
7. Early Stage VC 02-Jul-2025 Completed Generating Revenue
6. Early Stage VC 08-Jan-2025 Completed Generating Revenue
5. Early Stage VC (Series A1) 19-Dec-2023 Completed Generating Revenue
4. Early Stage VC 17-May-2022 Completed Generating Revenue
3. Early Stage VC 24-Feb-2022 Completed Generating Revenue
2. Seed Round 09-Oct-2021 Completed Startup
1. Seed Round 01-Jul-2021 Completed Startup
To view HemaCell’s complete valuation and funding history, request access »

HemaCell Investors (25)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hebei Coastal Industry Investment Fund Government Minority
Penglai Capital Venture Capital Minority
Vagangian Capital Asset Manager Minority
CDH Shanghai Dinghui Bai Fu Wealth Management Growth/Expansion Minority
Leader Venture Capital Growth/Expansion Minority
You’re viewing 5 of 25 investors. Get the full list »

Ready to get started?

Request a free trial

HemaCell FAQs

  • When was HemaCell founded?

    HemaCell was founded in 2021.

  • Where is HemaCell headquartered?

    HemaCell is headquartered in Suzhou, China.

  • What industry is HemaCell in?

    HemaCell’s primary industry is Drug Discovery.

  • Is HemaCell a private or public company?

    HemaCell is a Private company.

  • What is HemaCell’s current revenue?

    The current revenue for HemaCell is .

  • How much funding has HemaCell raised over time?

    HemaCell has raised $29.9M.

  • Who are HemaCell’s investors?

    Hebei Coastal Industry Investment Fund, Penglai Capital, Vagangian Capital, CDH Shanghai Dinghui Bai Fu Wealth Management, and Leader Venture Capital are 5 of 25 investors who have invested in HemaCell.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process